Valiant Laboratories Limited EBITDA for the year ending March 31, 2024: USD -1.03 M

Valiant Laboratories Limited EBITDA is USD -1.03 M for the year ending March 31, 2024, a -121.21% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2023 was USD 4.86 M, a -16.62% change year over year.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2022 was USD 5.83 M, a -16.97% change year over year.
  • Valiant Laboratories Limited EBITDA for the year ending March 31, 2021 was USD 7.02 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)